Buscar
Mostrando ítems 1-10 de 11
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
(Taylor and Francis Ltd, 2019)
A metabolic perspective of late onset Alzheimer's disease
(Academic Press, 2019)
GLP-1 and GIP receptor agonists in the treatment of Parkinson’s disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies
(2021-08-01)
Background Parkinson’s disease (PD) is a progressive multifactorial neurodegenerative condition. Epidemiological studies have shown that patients with type 2 diabetes mellitus (T2DM2) are at increased risk for developing ...
Insulin Secretion In Insulin Resistance States
(Nova Science Publishers, Inc., 2010)
Coffee Intake And Obesity
(Elsevier Inc., 2014)